Avalon GloboCare Corp. Market Cap ($2.87 Million)
Market Cap & Net Worth: Avalon GloboCare Corp. (ALBT)
Avalon GloboCare Corp. market cap. Avalon GloboCare Corp. (NASDAQ:ALBT) has a market capitalization of $2.87 Million ($2.87 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29546 globally and #6034 in its home market, demonstrating a -24.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avalon GloboCare Corp.'s stock price $0.22 by its total outstanding shares 13147651 (13.15 Million). Also see how efficiently does Avalon GloboCare Corp. generate cash for how efficiently the company converts equity into cash flow.
Avalon GloboCare Corp. Market Cap History (2016–2026)
Avalon GloboCare Corp. market cap history from 2016 to 2026. Data shows change from $244.55K to $2.87 Million (-11.37% CAGR). Check latest Avalon GloboCare Corp. stock price today for real-time trading data and today's change.
Index Memberships
Avalon GloboCare Corp. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2723 of 3165 |
Weight: Avalon GloboCare Corp.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Avalon GloboCare Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avalon GloboCare Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Avalon GloboCare Corp. equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
32.14x
Avalon GloboCare Corp.'s market cap is 32.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $244.55K | $616.45K | $55.58K | 0.40x | 4.40x |
| 2017 | $219.57K | $1.08 Million | -$3.46 Million | 0.20x | N/A |
| 2018 | $5.42 Billion | $1.56 Million | -$7.77 Million | 3471.46x | N/A |
| 2019 | $3.81 Billion | $1.55 Million | -$18.07 Million | 2461.51x | N/A |
| 2020 | $2.21 Billion | $1.38 Million | -$12.68 Million | 1603.18x | N/A |
| 2021 | $1.62 Billion | $1.39 Million | -$9.09 Million | 1162.61x | N/A |
| 2022 | $1.03 Billion | $1.20 Million | -$11.93 Million | 853.06x | N/A |
| 2023 | $95.25 Million | $1.26 Million | -$16.71 Million | 75.86x | N/A |
| 2024 | $42.86 Million | $1.33 Million | -$7.90 Million | 32.14x | N/A |
Competitor Companies of ALBT by Market Capitalization
Companies near Avalon GloboCare Corp. in the global market cap rankings as of November 3, 2026. Also see Avalon GloboCare Corp. assets under control for a full breakdown of the balance sheet.
Key companies related to Avalon GloboCare Corp. by market ranking:
- Vingroup JSC (VN:VIC): Ranked #412 globally with a market cap of $68.95 Billion USD ( ₫1814.70 Trillion VND).
- CBRE Group Inc Class A (NYSE:CBRE): Ranked #661 globally with a market cap of $40.04 Billion USD.
- DCI Indonesia Tbk PT (JK:DCII): Ranked #1080 globally with a market cap of $24.16 Billion USD ( Rp412.39 Trillion IDR).
- VONOVIA SE ADR 1/2/O.N (F:VNAA): Ranked #1175 globally with a market cap of $21.78 Billion USD ( €18.63 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #412 | Vingroup JSC | VN:VIC | $68.95 Billion | ₫242000.00 |
| #661 | CBRE Group Inc Class A | NYSE:CBRE | $40.04 Billion | $136.75 |
| #1080 | DCI Indonesia Tbk PT | JK:DCII | $24.16 Billion | Rp173000.00 |
| #1175 | VONOVIA SE ADR 1/2/O.N | F:VNAA | $21.78 Billion | €11.50 |
Market Capitalization of Avalon GloboCare Corp. (2016–2026)
Market capitalization of Avalon GloboCare Corp. from 2016 to today. Between 2016 and today, Avalon GloboCare Corp.'s market cap moved from $244.55K to $ 2.87 Million, with a yearly change of -11.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.87 Million | -81.80% |
| 2025 | $15.78 Million | -63.19% |
| 2024 | $42.86 Million | -55.00% |
| 2023 | $95.25 Million | -90.71% |
| 2022 | $1.03 Billion | -36.59% |
| 2021 | $1.62 Billion | -26.79% |
| 2020 | $2.21 Billion | -41.97% |
| 2019 | $3.81 Billion | -29.82% |
| 2018 | $5.42 Billion | +2469959.88% |
| 2017 | $219.57K | -10.22% |
| 2016 | $244.55K | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Avalon GloboCare Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.87 Million USD |
| MoneyControl | $2.87 Million USD |
| MarketWatch | $2.87 Million USD |
| marketcap.company | $2.87 Million USD |
| Reuters | $2.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI … Read more